Dietary pterostilbene is a novel chemopreventive and therapeutic agent in prostate cancer: Pre-clinical studies

被引:0
|
作者
Levenson, Anait [1 ]
机构
[1] Long Isl Univ, Arnold & Marie Schwartz Coll Pharm & Hlth Sci, Brooklyn, NY USA
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
178
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Dietary pterostilbene is a novel MTA1-targeted chemopreventive and therapeutic agent in prostate cancer
    Dhar, Swati
    Kumar, Avinash
    Zhang, Liangfen
    Rimando, Agnes M.
    Lage, Janice M.
    Lewin, Jack R.
    Atfi, Azeddine
    Zhang, Xu
    Levenson, Anait S.
    ONCOTARGET, 2016, 7 (14) : 18469 - 18484
  • [2] Dietary Supplement 4-Methylumbelliferone: An Effective Chemopreventive and Therapeutic Agent for Prostate Cancer
    Yates, Travis J.
    Lopez, Luis E.
    Lokeshwar, Soum D.
    Ortiz, Nicolas
    Kallifatidis, Georgios
    Jordan, Andre
    Hoye, Kelly
    Altman, Norman
    Lokeshwar, Vinata B.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2015, 107 (07):
  • [3] Resveratrol and pterostilbene as a microRNA-mediated chemopreventive and therapeutic strategy in prostate cancer
    Kumar, Avinash
    Rimando, Agnes M.
    Levenson, Anait S.
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 2017, 1403 (01) : 15 - 26
  • [4] Therapeutic Potential of Gnetin C in Prostate Cancer: A Pre-Clinical Study
    Gadkari, Ketaki
    Kolhatkar, Urvi
    Hemani, Rutu
    Campanelli, Gisella
    Cai, Qing
    Kumar, Avinash
    Levenson, Anait S.
    NUTRIENTS, 2020, 12 (12) : 1 - 15
  • [5] Novel prostate cancer mouse models for testing targeted chemopreventive potential of pterostilbene
    Hemani, Rutu
    Inamdar, Ninad
    Kumar, Avinash
    Donovan, Virginia
    Levenson, Anait S.
    CANCER RESEARCH, 2020, 80 (16)
  • [6] In vitro models for the pre-clinical evaluation of promising chemopreventive and therapeutic molecules
    Colacci, A
    Vaccari, M
    Mascolo, MG
    Chiozzotto, D
    Severini, C
    Zanghi, L
    Sacchetti, C
    Grilli, S
    Silingardi, P
    Horn, W
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2004, 197 (03) : 180 - 181
  • [7] PRE-CLINICAL STUDIES OF A NOVEL ANTI-MITOTIC AGENT, AMPHETHINILE
    MCGOWN, AT
    EWEN, C
    SMITH, DB
    FOX, BW
    BRITISH JOURNAL OF CANCER, 1988, 57 (02) : 157 - 159
  • [8] Application of the transgenic adenocarcinoma mouse prostate (TRAMP) model for pre-clinical therapeutic studies
    Martiniello-Wilks, R
    Dane, A
    Mortensen, E
    Jeyakumar, G
    Wang, XY
    Russell, PJ
    ANTICANCER RESEARCH, 2003, 23 (3B) : 2633 - 2642
  • [9] A Novel, Spontaneously Immortalized, Human Prostate Cancer Cell Line, Bob, Offers a Unique Model for Pre-Clinical Prostate Cancer Studies
    Attard, Gerhardt
    Rizzo, Sian
    Ledaki, Ioanna
    Clark, Jeremy
    Reid, Alison H. M.
    Thompson, Alan
    Khoo, Vincent
    de Bono, Johann S.
    Cooper, Colin S.
    Hudson, David L.
    PROSTATE, 2009, 69 (14): : 1507 - 1520
  • [10] PRE-CLINICAL EVALUATION OF THE NOVEL THERAPIES OF THE CASTRATION-RESISTANT PROSTATE CANCER
    Charbit, David
    El Sayed, Ihsan
    Masson-Lecomte, Alexandra
    Saldana, Carolina
    Salomon, Laurent
    Vacherot, Francis
    De La Taille, Alexandre
    JOURNAL OF UROLOGY, 2015, 193 (04): : E676 - E676